These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21728320)

  • 21. Nano spray dryer for vectorizing α-galactosylceramide in polymeric nanoparticles: A single step process to enhance invariant Natural Killer T lymphocyte responses.
    Gonzatti MB; Sousa MEP; Tunissi AS; Mortara RA; de Oliveira AM; Pereira Cerize NN; Keller AC
    Int J Pharm; 2019 Jun; 565():123-132. PubMed ID: 31075434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model.
    Kim JO; Kim DH; Chang WS; Hong C; Park SH; Kim S; Kang CY
    J Allergy Clin Immunol; 2004 Dec; 114(6):1332-8. PubMed ID: 15577831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity.
    Lee A; Farrand KJ; Dickgreber N; Hayman CM; Jürs S; Hermans IF; Painter GF
    Carbohydr Res; 2006 Dec; 341(17):2785-98. PubMed ID: 17014832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands.
    Pauwels N; Aspeslagh S; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2012 Dec; 20(24):7149-54. PubMed ID: 23122935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions.
    Doisne JM; Becourt C; Amniai L; Duarte N; Le Luduec JB; Eberl G; Benlagha K
    J Immunol; 2009 Aug; 183(3):2142-9. PubMed ID: 19587013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
    Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
    Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo.
    Simkins HM; Hyde E; Farrand KJ; Ong ML; Degli-Esposti MA; Hermans IF; Ronchese F
    J Leukoc Biol; 2011 May; 89(5):753-62. PubMed ID: 21297009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profound invariant natural killer T-cell deficiency in inflammatory arthritis.
    Tudhope SJ; von Delwig A; Falconer J; Pratt A; Woolridge T; Wilson G; Isaacs JD; Ng WF
    Ann Rheum Dis; 2010 Oct; 69(10):1873-9. PubMed ID: 20444757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
    J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
    Joyee AG; Uzonna J; Yang X
    J Immunol; 2010 Feb; 184(4):2095-106. PubMed ID: 20089704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro proliferation and cytokine production of Vα24+Vβ11+ natural killer T cells in patients with systemic lupus erythematosus.
    Yu XM; Wang XF
    Chin Med J (Engl); 2011 Jan; 124(1):61-5. PubMed ID: 21362309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY alpha-galactosylceramide.
    Vo-Hoang Y; Micouin L; Ronet C; Gachelin G; Bonin M
    Chembiochem; 2003 Jan; 4(1):27-33. PubMed ID: 12512073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
    Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
    J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids.
    Arora P; Venkataswamy MM; Baena A; Bricard G; Li Q; Veerapen N; Ndonye R; Park JJ; Lee JH; Seo KC; Howell AR; Chang YT; Illarionov PA; Besra GS; Chung SK; Porcelli SA
    J Am Chem Soc; 2011 Apr; 133(14):5198-201. PubMed ID: 21425779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    Clin Immunol; 2008 Oct; 129(1):145-54. PubMed ID: 18707922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.